CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway
Cited by 68
Related Papers
Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
|Journal of Nanobiotechnology|2021|67
CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway
|International Journal of Oncology|2018|60
CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway
|Oncology Reports|2019|48
ADAM17-regulated CX3CL1 expression produced by bone marrow endothelial cells promotes spinal metastasis from hepatocellular carcinoma
|International Journal of Oncology|2020|35